PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208

Colorectal cancer (CRC) is the third most common cancer worldwide. The standard treatment in locally advanced rectal cancer is preoperative radiation alone or in combination with chemotherapy, followed by adjuvant chemotherapy. Rectal cancer is highly lethal, with only 20% of patients showing a comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Galván, Sandra, Rivero, Maria, Peinado-Serrano, Javier, Martinez-Pérez, Julia, Fernández-Fernández, MC, José Ortiz, María, García-Heredia, José M., Carnero, Amancio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291071/
https://www.ncbi.nlm.nih.gov/pubmed/32344898
http://dx.doi.org/10.3390/cells9051071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291071/
https://www.ncbi.nlm.nih.gov/pubmed/32344898
http://dx.doi.org/10.3390/cells9051071

Ejemplares similares